Review of Optometry
PRESENTS
Practice Pearl of the Week
 
Volume 1, Number 19
September 6, 2010
 

Welcome to Review of Optometry's Practice Pearl of the Week series. Optometrist Paul Karpecki will provide you invaluable clinical information and management strategies for a host of ocular conditions—from dry eye and corneal infection to retinal artery occlusion and neuro-ophthalmic disease.

How should I manage and educate patients with Fuchs' dystrophy?
 

Fuchs' is one of the most common dystrophies that we diagnose in eye care. The clinical picture of Fuchs' dystrophy reveals the presence of corneal guttata as the remaining endothelial cells spread to cover as much of the cornea's back surface as possible. Guttata associated with Fuchs' dystrophy typically present bilaterally and are often located centrally. (Be careful not to confuse Fuchs'-related guttata with peripheral guttata, which simply could be caused by age-related changes. Specular microscopy might be the only way to correctly differentiate the findings.)

Patients with Fuchs' dystrophy often present with a chief complaint of blurred vision in the morning. Also, they may occasionally demonstrate other associated findings, such as corneal haze, edema or even bullae.

An absolute diagnosis of Fuchs' dystrophy can be confirmed via specular microscopy. In this instance, specular microscopy often will reveal early signs of stress on the endothelium as well as a cell density measurement of less than 800. However, in the meantime, the slit lamp findings, pachymetry changes and duration of morning blur will assist you in determining when a patient may need to be educated about future surgical treatment options.

It is best to educate Fuchs' dystrophy patients as early as possible. You must inform them that it is a progressive, hereditary condition that will eventually require surgical intervention. The good news is that surgical options for Fuchs' dystrophy have improved vastly during the last several years. Contemporary surgical options, such as endothelial transplants or DSEK (Descemet's scraping endothelial keratoplasty), no longer require sutures or re-epithelialization and do not cause significant induced astigmatism. You can also use hyperosmotic drops, such as Muro 128 (sodium chloride, Baush + Lomb) or FreshKote (Focus Laboratories), to help reduce edema and alleviate some of the endothelial cell stress—both of which may prolong the need for corneal transplant.

Until you see significant symptom progression, you should schedule the patient for follow-up every six months. Also, it is best to schedule such examinations in the morning, because it will help you better determine the patient's true level of visual debilitation. Although specular microscopy is the best way to monitor patients with Fuchs' dystrophy, other methods to monitor disease progression include pachymetry measurement and morning visual acuity assessment.

The bottom line:

  • If the patient's vision deteriorates to 20/50 or worse and he or she is unable to function normally (or his or her vision does not recover within two to three hours after waking in the morning), consider referring the patient to a corneal surgeon for DSEK.
  • When the patient's corneal thickness increases to 600µm, it is time to begin discussing a transplant (assuming average corneal thickness is approximately 550µm). If/when the cornea reaches 640µm, most patients will require surgical intervention.


"Do what you can, with what you have, where you are."
– Theodore Roosevelt


 
DIAMOND LEVEL SPONSOR
 

 

 
SILVER LEVEL SPONSORS
 

For information on how to become one of the sponsors of Practice Pearls, please contact Review's publisher Rick Bay (rbay@jobson.com) or sales managers James Henne (jhenne@jobson.com), Michele Barrett (mbarrett@jobson.com), or Kimberly McCarthy (kmccarthy@jobson.com) for more details and pricing.

CLICK HERE
TO VIEW THE PRACTICE PEARL ARCHIVES!

Review of Optometry

http://www.facebook.com/revoptom http://www.twitter.com/revoptom

 

 

 

This paid, promotional message was sent to you directly by Jobson Professional Publications Group, a division of Jobson Medical Information LLC, 11 Campus Blvd., Newtown Square, PA 19073, as part of its continuing mission to keep the eyecare profession informed.

If you do not want to receive this type of information in the future, click here

Jobson Professional Publications never releases its e-mail list.